TPIDB > 臨床試驗主持人
臨床試驗主持人
更新時間：2023-09-19
姚明YAO, MING
- 計畫主持人
- 執行臨床試驗年資 23 年 9 個月
發表文獻
13筆
11
Lee CC, Chang HH, Lu MY, Yang YL, Chou SW, Lin DT, Jou ST, Yao M, Li CC, Yeh SP, Chen MH, Gau JP, Li SS, Wang PN, Liu YC, Wang TF, Tan TD, Lee MY, Yu MS, Wang CC, Lin SC, Chen YC, Su YC, Su KY, Lin KH. The incidence and risk factors of hepatic veno-occlusive disease after hematopoietic stem cell transplantation in Taiwan. Ann Hematol. 2019 Mar;98(3):745-752. doi: 10.1007/s00277-019-03604-2. Epub 2019 Jan 21. PMID: 30666432.
12
Huang TC, Huang SY, Yao M, Lin CY, Hwang WL, Gau JP, Tan TD, Wang PN, Liu YC, Lin SC, Kao RH, Pei SN, Yu MS, Lin HY, Su YC, Chen CC, Li SS, Wu YY. Autologous stem cell transplantation in multiple myeloma: Post-transplant outcomes of Taiwan Blood and Marrow Transplantation Registry. J Formos Med Assoc. 2019 Jan;118(1 Pt 3):471-480. doi: 10.1016/j.jfma.2018.07.020. Epub 2018 Aug 16. PMID: 30119948.
13
Huang MS, Chen YH, Wang CW, Yao M, Kuo SH. Low-dose splenic irradiation is an alternative therapy for symptomatic splenomegaly in patients with myelofibrosis. Ann Hematol. 2019 Apr;98(4):1037-1040. doi: 10.1007/s00277-018-3461-z. Epub 2018 Jul 30. PMID: 30062500.
1
2
